Posted by ABMN Staff on Apr 26th, 2024
Investment analysts at StockNews.com started coverage on shares of VolitionRx (NYSE:VNRX – Get Free Report) in a report issued on Friday. The brokerage set a “sell” rating on the stock.
Separately, Cantor Fitzgerald...
More of this article »